The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Sangamo BioSciences Inc  (SGMO) Trade Now »     Rate SGMO  -  Discuss SGMO  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate SGMO:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

SGMO: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on SGMO ... Graphic_rating_buy SGMO
074
76%
 +80.00%
in 26 days
(closed on 12/09/08)
Fortunately I test all falling knives on my actual portfolio. I think this is a low as it'll go on the failed trial news.
By  Jeremy McDonald   (+7.04%  risk: conservative)  11/13/08 Comment




From the Blogosphere

Sangamo (SGMO): Progress in adult stem calls? Graphic_rating_buy SGMO
-31.14%
in 58 days

Filed under: Newsletters, Stocks to Buy

"Sangamo BioSciences (NASDAQ: SGMO) has again received significant scientific validation for its proprietary technology," says biotech expert John McCamant.

In The Medical Technology Stock Letter, he explains, ""Part of what has gotten investors so excited about stem cells was the concept that some day scientists would be able to create 'personalized' stem cell types for individual therapy. We believe that this is the break that was needed to realize the potential of stem cell therapy."

<>"Stem cells differ from other cell types in two fundamental ways. Fi...
By  Steven Halpern   (+5.64%  risk: moderate)  10/02/09 Comment


Sangamo (SGMO): Progress in adult stem calls?
16%

"Sangamo BioSciences (NASDAQ: SGMO) has again received significant scientific validation for its proprietary technology," says John McCamant.

In The Medical Technology Stock Letter, the biotech specialist adds, "Part of the excitement about stem cells is the concept that one day scientists will be able to create 'personalized' stem cell types for individual therapy. This could be the break needed to realize this potential."

"Stem cells differ from other cell types in two fundamental ways. First, they are unspecialized cells capable of renewing themselves through cell division. 

<>"Second...
By  The Stock Advisors   (-17.04%  risk: moderate)  09/22/09 Comment


Analyst upgrades, downgrades and initiations: AKAM, MRVL, THRX, DELL, CRNT, TRV, AEIS ...

Filed under: Analyst reports, Analyst upgrades and downgrades, Dell (DELL), Chubb Corp (CB), Analyst initiations, Akamai Technologies (AKAM), Marvell Technology Group (MRVL)

Analyst upgrades:
<>
  • Citigroup upgraded shares of Akamai (NASDAQ: AKAM) to Buy from Hold following the company's Q4 results as they believe fundamentals are stabilizing. The firm raised their target price to $22 from $12.
    • <>Baird upgraded Theravance (NASDAQ: THRX) to Outperform from Neutral. The firm said the company looks poised to realize the two-product success necessary to drive profitability, and Horizon will like...
    By  Eric Buscemi   (+0.00%)  02/05/09 Comment


    Agreements Boost Sangamo Biosci Graphic_rating_buy SGMO
    -49.62%
    in 505 days
    The company also plans to initiate two candidates into phase I trials for brain cancer and HIV in the second half of the year. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis t...
    By  Zacks.com   (-13.23%  risk: moderate)  07/11/08 Comment


    Pre-Market Gappers
    Gapping up:

    GTCB +19.6%, LDK +15.8%, NVAX +13.9%, SGEN +8.0%, OSIR +7.9%, VIP +7.4%, KEG +6.4% , EPCT +4.9%, WCI +3.7%, NICE +3.4%, RATE +3.3%, CC +3.1%, FREE +3.0%, QCCO +2.8%, UBS +2.8%, LZB +2.8%, DCP +2.1%, CDE +2.0%, JPM +1.9%, CCL +1.8%, MCD +1.4%, GSOL +1.3%, CX +1.0%, FRE +1.0%...

    Gapping down:

    AMC -41.4%, HEB -18.6%, LTRE -4.6%, SGMO -4.1%, NAVI -4.0%, HAYZ -3.2%, RHT -3.0%, KOSN -2.8%, EXAR -2.6%, AMGN -2.5%, GEOY -1.5%, BHP -1.2%, VMC -1.1%.
    By  visualtrader.blogspot.com   (-40.16%  risk: aggressive)  12/10/07 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.25% 381
    2 Gerald Greene 18.14 +72.34% 210
    3 stockmarketfunding.com 17.66 +25.65% 55
    4 akiralegrand 13.47 +14.32% 62
    5 anup2104 12.13 +76.91% 39


    POPULAR STOCKS
    Symbol Company Name Sentiment
    T AT&T Inc
    C Citigroup Inc
    AMD Advanced Micro Devices Inc
    MA MasterCard Inc
    WMT WalMart Stores Inc
    PG The Procter & Gamble Company

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on SGMO

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Sangamo BioSciences Inc - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch